Nov 21 (Reuters) - Palatin Technologies PTN.A
* Palatin Technologies announces signing of licensing
agreement
with Kwangdong Pharmaceutical for Republic of Korea
* A NDA anticipated to be filed with U.S. Food and Drug
Administration in Q1 of calendar year 2018
Source text for Eikon: ID:nPn4Rm8GVa
Further company coverage: AMAG.O